• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过生命周期评估、质量改进、教育和技术创新提高肾脏医疗保健的可持续性和质量:KitNewCare方法。

Improving the sustainability and quality of kidney health care through life cycle assessments, quality improvement, education and technical innovations: the KitNewCare approach.

作者信息

Duane Brett, Steinbach Ingeborg, Stancliffe Rachel, Barna Stefi, Cameron David, de Barbieri Ilaria, Noruisiene Edita, Mortimer Frances, Gerritsen Karin, Vanholder Raymond, Donati Gabriele, Alfano Gaetano, Malyszko Jolanta, Ligabue Giulia, Johnston Bridget, Wratten Mary Louise, Caiazzo Marialuisa, Schmid Elisabeth, Ortiz Alberto

机构信息

Sustainability in Healthcare Lead, Trinity College Dublin, School of Dental Science, Dublin, Ireland.

Centre for Sustainable Healthcare, 8 King Edward Street, Oxford, OX1 4HL, UK.

出版信息

J Nephrol. 2025 Jan;38(1):87-99. doi: 10.1007/s40620-024-02114-3. Epub 2024 Nov 8.

DOI:10.1007/s40620-024-02114-3
PMID:39511063
Abstract

The European Union (EU)-funded KitNewCare consortium aims to create and manage a comprehensive EU-wide programme focusing on sustainability in Kidney Care. Around 850 million people have chronic kidney disease (CKD) worldwide and by 2030, 6 million will need kidney replacement therapy, mainly haemodialysis. As the world population gets older, projections for the end of the century worsen. From a sustainability perspective, healthcare systems contribute around 5-11% of total carbon emissions. Kidney care is one of the most resource-intensive specialties. In addition to energy, haemodialysis and peritoneal dialysis require transportation of patients and personnel to and from facilities, use large volumes of water and generate significant plastic waste. Overall, current dialysis is not sustainable in the medium term. Primary prevention, early diagnosis and treatment of CKD and transplantation will decrease the need for dialysis, but this will take time and will not prevent the need for dialysis in millions of persons. There is a need to improve knowledge around the environmental and financial cost of kidney care and social and health outcomes of each patient pathway including using holistic tools such as life cycle assessment. This knowledge will allow workflow optimisations, organisational transformations and technological innovations across Europe, learning from different clinical sites. KitNewCare will build a European-wide knowledge base for sustainability in kidney care, develop and introduce a novel 4-factor database for comprehensive impact analysis, implement optimised processes and organisational transformations in four European clinical sites. It will also pilot innovations from small- and medium-sized high-tech enterprises with a focus on kidney care, and establish a network for continuous monitoring, benchmarking, and implementation of sustainable solutions across healthcare sectors. This paper presents the rationale behind selecting kidney disease as a focal point, summarises the current state of knowledge, and outlines the foundational statement underlying KitNewCare's operational framework.

摘要

由欧盟资助的KitNewCare联盟旨在创建并管理一项全欧盟范围的综合性计划,重点关注肾脏护理的可持续性。全球约有8.5亿人患有慢性肾脏病(CKD),到2030年,600万人将需要肾脏替代治疗,主要是血液透析。随着世界人口老龄化,对本世纪末的预测更加严峻。从可持续性角度来看,医疗保健系统占总碳排放量的5%-11%左右。肾脏护理是资源最密集的专科之一。除能源外,血液透析和腹膜透析需要运送患者和医护人员往返医疗机构,消耗大量水,并产生大量塑料垃圾。总体而言,目前的透析在中期是不可持续的。CKD的一级预防、早期诊断和治疗以及移植将减少透析需求,但这需要时间,而且无法避免数百万人对透析的需求。有必要提高对肾脏护理的环境和财务成本以及每个患者治疗途径的社会和健康结果的认识,包括使用生命周期评估等整体工具。这些知识将有助于在欧洲各地优化工作流程、进行组织变革和技术创新,从不同的临床场所汲取经验。KitNewCare将建立一个全欧洲范围的肾脏护理可持续性知识库,开发并引入一个新颖的四因素数据库用于全面影响分析,在四个欧洲临床场所实施优化流程和组织变革。它还将试点中小型高科技企业针对肾脏护理的创新,并建立一个网络,用于持续监测、基准评估以及在各医疗保健部门实施可持续解决方案。本文阐述了选择肾脏疾病作为重点的基本原理,总结了当前的知识状况,并概述了KitNewCare运营框架的基本声明。

相似文献

1
Improving the sustainability and quality of kidney health care through life cycle assessments, quality improvement, education and technical innovations: the KitNewCare approach.通过生命周期评估、质量改进、教育和技术创新提高肾脏医疗保健的可持续性和质量:KitNewCare方法。
J Nephrol. 2025 Jan;38(1):87-99. doi: 10.1007/s40620-024-02114-3. Epub 2024 Nov 8.
2
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.接受透析治疗并等待已故捐赠者肾脏移植的成年人的经历:一项系统综述。
JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973.
3
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
4
Remote patient monitoring and management in nephrology: A systematic review.远程肾病患者监测和管理:系统综述。
Nefrologia (Engl Ed). 2024 Sep-Oct;44(5):639-667. doi: 10.1016/j.nefroe.2024.10.011.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
7
Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.慢性肾脏病多种治疗时代未来肾脏保护试验的设计考量
Nephrol Dial Transplant. 2025 Feb 5;40(Supplement_1):i70-i79. doi: 10.1093/ndt/gfae210.
8
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
9
Education programmes for people with chronic kidney disease and diabetes.针对慢性肾脏病和糖尿病患者的教育计划。
Cochrane Database Syst Rev. 2024 Aug 22;8(8):CD007374. doi: 10.1002/14651858.CD007374.pub3.
10
Interventions for chronic kidney disease-associated restless legs syndrome.慢性肾脏病相关不宁腿综合征的干预措施。
Cochrane Database Syst Rev. 2016 Nov 7;11(11):CD010690. doi: 10.1002/14651858.CD010690.pub2.

引用本文的文献

1
Sustainable health care in a renal centre - carbon saving is coupled with cost-efficiency.肾脏中心的可持续医疗保健——碳减排与成本效益相结合。
J Nephrol. 2025 Jul 23. doi: 10.1007/s40620-025-02354-x.

本文引用的文献

1
The evaluation of kidney transplant candidates prior to waitlisting: a scoping review.等待名单前肾移植候选者的评估:一项范围综述
Clin Kidney J. 2024 Nov 22;18(1):sfae377. doi: 10.1093/ckj/sfae377. eCollection 2025 Jan.
2
Green nephrology for the nephrology curriculum? Opinions of Italian nephrology residents.肾脏科课程中的绿色肾脏病学?意大利肾脏科住院医师的看法。
J Nephrol. 2024 Dec;37(9):2679-2682. doi: 10.1007/s40620-024-02140-1. Epub 2024 Nov 23.
3
Heterogeneity in the incidence of kidney replacement therapy across Europe: a benchmarking tool to improve clinical practice.
欧洲肾脏替代治疗发病率的异质性:一种改善临床实践的基准工具。
Clin Kidney J. 2024 May 21;17(7):sfae155. doi: 10.1093/ckj/sfae155. eCollection 2024 Jul.
4
The Carbon Footprint of Peritoneal Dialysis in Australia.澳大利亚腹膜透析的碳足迹。
J Am Soc Nephrol. 2024 Aug 1;35(8):1095-1103. doi: 10.1681/ASN.0000000000000361. Epub 2024 Apr 26.
5
The ERA Registry Annual Report 2021: a summary.《2021年ERA注册机构年度报告》摘要
Clin Kidney J. 2023 Nov 15;17(2):sfad281. doi: 10.1093/ckj/sfad281. eCollection 2024 Feb.
6
Eco-dialysis in Italy: where are we? National survey on the eco-sustainability of dialysis across Italian dialysis centers.意大利的生态透析:我们处于什么状况?关于意大利透析中心透析生态可持续性的全国性调查。
J Nephrol. 2024 Apr;37(3):781-784. doi: 10.1007/s40620-023-01882-8. Epub 2024 Mar 1.
7
Prioritizing water stewardship in kidney replacement therapies.在肾脏替代治疗中优先考虑水资源管理。
Kidney Int. 2023 Oct;104(4):857. doi: 10.1016/j.kint.2023.07.016.
8
The Spanish Scientific Societies before the ESC 2021 guidelines on vascular disease prevention: Generalizing the measurement of albuminuria to identify vascular risk and prevent vascular disease.西班牙科学学会在 2021 年 ESC 血管疾病预防指南之前:推广白蛋白尿测量以识别血管风险并预防血管疾病。
Nefrologia (Engl Ed). 2023 Mar-Apr;43(2):245-250. doi: 10.1016/j.nefroe.2023.06.005. Epub 2023 Jul 3.
9
Coordinating efforts to optimize next-generation kidney replacement therapies: the European Kidney Health Alliance Work Group 'Breakthrough Innovation'.协调各方努力以优化下一代肾脏替代疗法:欧洲肾脏健康联盟工作组“突破性创新”
Clin Kidney J. 2023 Jan 27;16(6):885-890. doi: 10.1093/ckj/sfad016. eCollection 2023 Jun.
10
Water implications in dialysis therapy, threats and opportunities to reduce water consumption: a call for the planet.透析治疗中的水问题,减少水耗的威胁与机遇:为地球呼吁。
Kidney Int. 2023 Jul;104(1):46-52. doi: 10.1016/j.kint.2023.04.008. Epub 2023 Apr 26.